Effects of Aβ1‐42 on the current of KATP channels in cultured cholinergic neurons

Shuhui Tan1, Guozhao Ma, Yanju Li

  • 1Department of Neurology, Provincial Hospital affiliated to Shandong University, Jinan, China.

Neurological Research
|August 15, 2012
PubMed
Abstract

Insights

Beta-amyloid peptides (Abeta(1-42)) inhibit ATP-sensitive potassium (K(ATP)) channels in neurons. Pretreatment with Diazoxide, a K(ATP) channel opener, prevents this inhibition, suggesting a neuroprotective role for K(ATP) channel activation against Abeta(1-42) toxicity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Beta-amyloid peptides (Abeta(1-42)) are implicated in neurodegenerative diseases.
  • Cholinergic neurons are crucial for cognitive functions.
  • ATP-sensitive potassium (K(ATP)) channels are involved in neuronal function and survival.

Purpose of the Study:

  • To investigate the effect of Abeta(1-42) on K(ATP) channels in cultured cortical and hippocampal cholinergic neurons.
  • To determine the neuroprotective potential of Diazoxide, a K(ATP) channel opener, against Abeta(1-42)-induced neurotoxicity.

Main Methods:

  • Primary rat cortical and hippocampal cholinergic neurons were cultured.
  • Whole-cell patch-clamp technique was employed to measure membrane currents.
  • The effects of Abeta(1-42) and Diazoxide on neuronal currents were assessed.

Main Results:

  • Abeta(1-42) significantly decreased outward currents in neurons (P<0.05).
  • Diazoxide alone did not alter the outward current.
  • Pretreatment with Diazoxide prevented the Abeta(1-42)-induced decrease in membrane current (P>0.05).

Conclusions:

  • Abeta(1-42) inhibits the opening of neuronal K(ATP) channels.
  • Diazoxide pretreatment mitigates the inhibitory effect of Abeta(1-42), indicating K(ATP) channel opening has a neuroprotective role.
  • Low-dose Diazoxide may be a therapeutic strategy for Abeta(1-42) neurotoxicity.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...